What is Genfit (GNFTfr)?
Genfit is a biopharmaceutical company focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of metabolic and liver-related diseases. The company specializes in addressing conditions such as non-alcoholic steatohepatitis (NASH) and other chronic liver diseases through its pipeline of drug candidates and diagnostic tools. Genfit's research efforts integrate molecular biology, clinical development, and biomarker identification to advance personalized medicine approaches. The company operates within the biotechnology sector and collaborates with academic institutions, research organizations, and industry partners to enhance its scientific and clinical programs. Genfit's activities encompass both early-stage research and clinical trials aimed at improving patient outcomes in areas with significant unmet medical needs. Its strategic focus includes leveraging its expertise in liver metabolism and inflammation to develop therapies that target underlying disease mechanisms. The company is headquartered in France and contributes to the global biopharmaceutical landscape through its innovative approach to liver disease management.
Genfit Stock Price Today: Live Overview
The price today is shaped by current trading flows as Genfit trades at €8.88. Price movements have spanned from €8.77 to €9.1, accompanied by a daily change of +0.5708%.
FAQ: Genfit (GNFTfr)
What is the current price of GNFTfr stock?
The current price stands at €8.88.
Does GNFTfr pay dividends?
The company does not currently pay dividends.
Does GNFTfr have a formal corporate presence or regional headquarters in the UAE?
Genfit operates in the UAE only through partners and distributors without an official office.
What is GNFTfr best known for?
Genfit is most famous for its development of therapeutics for liver diseases.
What assets are typically shown together with GNFTfr?
Commonly shown alongside GNFTfr: Gilead Sciences Inc, Rocket Pharmaceuticals Inc, Unusual Machines, Inc.
Latest shares articles



